Geode Capital Management, LLC Aim Immuno Tech Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 464,016 shares of AIM stock, worth $106,723. This represents 0.0% of its overall portfolio holdings.
Number of Shares
464,016
Previous 401,027
15.71%
Holding current value
$106,723
Previous $148,000
15.54%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AIM
# of Institutions
36Shares Held
9.01MCall Options Held
0Put Options Held
0-
Armistice Capital, LLC New York, NY4.33MShares$995,9000.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$457,4010.0% of portfolio
-
Black Rock Inc. New York, NY698KShares$160,6010.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il458KShares$105,2860.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny243KShares$55,9370.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $11.1M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...